Established in 1998 and formed by six companies under the management of the previous Ministry of Foreign Economic Relations and Trade, China General Technology (Group) Holding Co Ltd, or Genertec, is a centrally administered State-owned enterprise, which is directed by the State-owned Assets Supervision and Administration Commission of the State Council (SASAC). Since 2006, the Beijing-headquartered group reorganized five central SOEs - Chongqing Heavy-duty Vehicle Research Institute (later renamed as China Automotive Engineering Research Institute Co Ltd), China National Light Industrial Products Import and Export Group Co Ltd, China Textile Academy Co Ltd，China Xinxing Group Co Ltd and China Postal and Telecommunications Appliances Co Ltd, as well as a number of locally controlled SOEs, including Qiqihar No.2 Machine Tool (Group) Co Ltd, Harbin Measuring & Cutting Tools Group Co Ltd，Beijing Machine Tool Research Institute Co Ltd, General Technology Group Dalian Machine Tool Co Ltd and Shenyang Machine Tool (Group) Co Ltd.
Genertec was approved by the government as a pilot enterprise of State-owned capital investment in December 2018. Supported by more than 83,000 employees, Genertec ran 483 domestic units by the end of 2020, including 25 secondary level companies, and 91 business branches in overseas markets.
As an investment holding company, Genertec owns 4 listed companies in both Chinese mainland and Hong Kong Special Administrative Region – China Meheco Group Co Ltd, China Automotive Engineering Research Institute Co Ltd, Shenyang Machine Tool Co Ltd and Genertec Universal Medical Group Co Ltd (Hong Kong Stock Exchange listed company).
Genertec has taken the role of being a pilot State-owned capital investment company as a starting point, and introduced new measures to respond the government's call for high-quality development. We have been focusing on the three pillar businesses - advanced manufacturing and technical services, medicine and healthcare, trade and engineering services to promote and serve national strategies and business activities such as the strategy of upgrading China's manufacturing sector, Healthy China 2030 strategy and the common prosperity of the Belt and Road Initiative. We aim to build our company a role-model group based on characteristics including innovation, green growth, cutting-edge technologies, healthcare and internationalization.
Genertec gained 195.7 billion yuan and 7.82 billion yuan of sales revenue and profit, respectively, in 2020. Genertec had won the A-level in the performance evaluation of central SOEs for 11 consecutive years (2009-2019), and ranked 73rd in the 2020 ENR list of the world's 250 largest international contractors. It ranked 477th on the list of the Global Fortune 500 companies in 2020.
In the field of advanced manufacturing and technical services,Genertec earnestly studied and implemented the instructions of China's top leadership on developing the real economy and advanced manufacturing, revitalizing the equipment manufacturing and strengthening tackling key core technologies. It has deployed more resources to develop high-end CNC machine tools and set goals to become the core leader of China's machine tool industry. Based on the technology accumulation and assets of Beijing Machine Tool Research Institute Co Ltd，Qiqihar No.2 Machine Tool (Group) Co Ltd and Harbin Measuring & Cutting Tools Group Co Ltd, Genertec completed the reorganization of General Technology Group Dalian Machine Tool Co Ltd and Shenyang Machine Tool (Group) Co Ltd in 2019. With a relatively complete industrial layout and industrial chain, including ultra-precision CNC machine tools, CNC systems and key functional components, it has become the only SOE that takes the development of high-end CNC machine tools as Genertec's main business. In addition to holding the largest variety of products and the broadest service areas in the domestic market, Genertec has the strongest technical capabilities across China, providing the most high-end core equipment and solutions for key industries and areas.
In the field of new materials, Genertec owns key technologies in the fields of bio-based fibers, functional fibers and high-performance fibers independently. In particular, it is able to produce the new solvent-processed cellulose fiber, or lyocell fiber, which is recognized as a ‘green fiber’ by the international fiber industry. It is significant and practical for China’s textile industry to fight against pollution and promote its transformation and upgrading.
Genertec has been vigorously promoting the industrialization of new solvent-based cellulose fiber. At present, the project with annual output of 30,000 metric tons has been fully reached and the project with annual output of 60,000 tons has been successfully built and started to operate. After these moves, Genertec's production capacity will reach the biggest amount in China and take the second place in the global market. With Genertec completing the site selection to build a project with 330,000 tons of annual output, it plans to possess a production capacity of 300,000 to 500,000 tons within two or three years, becoming one of the world’s ‘champions’ in the field of manufacturing bio-based fibers.
In the field of medical and healthcare industry, Genertec's business covers the pharmaceutical manufacturing, commerce and trade, medical services and finance, health management and other fields, forming a relatively complete service chain. At present, Genertec's medical and health sector has two listed companies, namely China Meheco Group Co Ltd and Genertec Universal Medical Group Co Ltd.
In pharmaceutical industry, Genertec ranked 53rd among the top 100 pharmaceutical enterprises in China in 2019, while its pharmaceutical business ranked No. 5 among the national wholesale companies in pharmaceutical business and took the third position among the top 100 import and export enterprises of medicines and health products in China.
Genertec’s financial leasing business of medical equipment also ranks among the top in China, covering more than 2,000 medical institutions, and has built long-term strategic partnerships with nearly 100 top hospitals, hospital management companies, and physician associations in Europe and the United States.
With the strong support of the government, Genertec has reached cooperation with 17 central SOEs and locally-controlled SOEs in the area of medical services since 2018, it runs a total of 154 medical institutions with a total of 32,000 beds. Currently, Genertec's annual number of outpatient and emergency treatments exceeds 16 million in 21 provinces, autonomous regions and municipalities across China. Genertec, as a central SOE, has developed itself into a medical group with leading number of beds, complete network coverage and industrial chain.
In the field of trade and engineering services, Genertec has accumulated strong capabilities for international market development, business integration service, global resource integration, overseas project management and risk control. It is the main channel for the imports of major technological equipment in China and a main force of conducting ‘going global’ strategy. Over the past 70 years, it has imported and introduced more than $340 billion of advanced technologies and complete sets of equipment for various industries.
Among them, 156 key projects introduced from the former Soviet Union in the early years of the People's Republic of China laid a solid foundation for the country to develop manufacturing business. The company's vigorous participation in the tangible growth of the Belt and Road Initiative has also driven and promote Chinese standards, technologies and equipment to many parts of the world.
Apart from completing a total of $11 billion in international engineering contracting turnover in the fields of power, energy, rail transit and infrastructure, it has also conducted international production capacity cooperation projects with partners in more than 20 countries and regions around the world, involving light industry, textiles, chemicals, building materials, maritime transportation and other fields.
Genertec has strong integrated management capabilities and a relatively complete domestic and foreign marketing networks, logistics distribution networks, and has built a presence in more than 100 countries and regions. Genertec also is a comprehensive service provider for the supply chain of mobile communication terminal products. Backed by a complete network system, and efficient operation and management capabilities, it has been a leader in the field of terminal product distribution of mobile communication for many years.